Ueji, N.; Mase, Y.; Kubo, A.; Matsubara, H.; Chujo, S.; Matsui, Y.; Kondo, M.
Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment. Medicina 2023, 59, 1856.
https://doi.org/10.3390/medicina59101856
AMA Style
Ueji N, Mase Y, Kubo A, Matsubara H, Chujo S, Matsui Y, Kondo M.
Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment. Medicina. 2023; 59(10):1856.
https://doi.org/10.3390/medicina59101856
Chicago/Turabian Style
Ueji, Natsuki, Yoko Mase, Akiko Kubo, Hisashi Matsubara, Shinichiro Chujo, Yoshitsugu Matsui, and Mineo Kondo.
2023. "Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment" Medicina 59, no. 10: 1856.
https://doi.org/10.3390/medicina59101856
APA Style
Ueji, N., Mase, Y., Kubo, A., Matsubara, H., Chujo, S., Matsui, Y., & Kondo, M.
(2023). Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment. Medicina, 59(10), 1856.
https://doi.org/10.3390/medicina59101856
